Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EADO 2022 | EADO 2022 highlights

Eva Muñoz Couselo • 26 Apr 2022
EADO 2022
Melanoma Skin Cancer

Eva Muñoz Couselo, MD, PhD, Vall d’Hebrón Hospital, Barcelona, Spain, shares her highlights from the European Association of Dermato-Oncology (EADO) 2022 congress, including discussion on different treatment scenarios for both melanoma and skin cancer and how to manage patients including relapses. This interview took place at the EADO 2022 congress.

More from Eva Muñoz Couselo

1:14
Adjuvant and neoadjuvant clinical trials for melanoma
Eva Muñoz Couselo • 26 Apr 2022
1:03
Treating metastatic melanoma
Eva Muñoz Couselo • 26 Apr 2022
1:17
Treatment selection for stage III BRAF-mutant melanoma
Eva Muñoz Couselo • 26 Apr 2022

Related Videos

1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:12
Novel immunotherapeutic approaches to treat patients with melanoma
Christoffer Gebhardt • 9 Apr 2024
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals